Entry of taxonomy/keywords during proffered abstract submission was optional.
Not all abstracts will appear in search results.
|MO-EF-TRACK 4-7||Latent Space Arc Therapy Optimization|
N Bice1*, N Kirby1, D Nguyen2, C Kabat1, P Myers1, N Papanikolaou1, M Fakhreddine1, (1) UT Health San Antonio MD Anderson Cancer Center, San Antonio, Texas, (2) UT Southwestern Medical Center, Dallas, TX.
|MO-IePD-TRACK 6-7||Effective Organs-At-Risk Dose Sparing in Volumetric Modulated Arc Therapy Using a Half-Beam Technique in Whole Pelvic Irradiation|
H Park1*, J Park2,3, M Artz2,3, Y Zhang2,3, J Ricci4, H Jang5, S Huh2,3, (1) Ajou University School of Medicine, Suwon, South Korea, (2) University of Florida College of Medicine, Gainesville, FL, (3) University of Florida Health Proton Therapy Institute, Jacksonville, FL, (4) Orlando Health UF Health Cancer Center, Orlando, FL, (5) Dongguk University College Of Medicine, Gyeongju, South Korea
|PO-GePV-T-178||An Improved Statistical Model for Gamma Index Pass Rates in Intensity Modulated Radiation Therapy Patient-Specific Quality Assurance|
P. James Jensen*, William Donahue, Zhe Chen, Yale University School of Medicine, New Haven, CT
|PO-GePV-T-212||Evaluation of Elekta Unity IMRT Beam Complexity Using a Novel Leaf Sequencer and Shape Optimizer in the Monaco Treatment Planning System|
J St-Aubin*, J Snyder, S Yaddanapudi, R Flynn, D Hyer, University of Iowa Hospitals and Clinics, Iowa City, IA
|PO-GePV-T-233||Dosimetric Comparison of VMAT Prostate Plans Designed with 10MV Vs 18MV Photon Beams|
D Shvydka1, M Hajduk2*, (1) University of Toledo Health Science Campus, Toledo, OH, (2) ,University of Toledo Health Science Campus, Toledo, OH,
|PO-GePV-T-263||Evaluation of Treatment Plan Uncertainties for VMAT TBI|
I Duarte*, P Galavis, N Gerber, D Barbee, J Teruel, NYU Langone Health, New York, NY
|PO-GePV-T-316||Modulation Area Index (MAI): A Plan-Specific Metric for Quantifying VMAT Modulation Complexity|
B Wu*, R Gonzales, J Qian, L Lin, J Yu, H Li, S Han-Oh, Johns Hopkins University, Baltimore, MD
|PO-GePV-T-386||The Influence of Iso-Center Location, Beam Type and Lesion Size On Plan Specific QA in Lung SBRT|
Shahram Mashouf, PhD*, Anderson Bauer, MD and Sugata Tripathi, PhD, Marshfield Clinic Health System, Marshfield, WI
|PO-GePV-T-436||Analysis of Preclinical IMRT Plan Quality Versus Number of Beam Angles|
D Olivera Velarde1*, E Pearson1, B Aydogan1, H Halpern1, G Redler2, B Epel1, J Slagowski1, (1) University of Chicago, Chicago, IL, (2) H. Lee Moffitt Cancer Center, Tampa, FL
|SU-IePD-TRACK 5-3||Development of a Dynamic-Shield Applicator Enabling Intensity-Modulated Brachytherapy for the Treatment of Rectal Cancer|
A Thibodeau-Antonacci1*, T Vuong2, H Bekerat1,2, L Liang1,2, S Abbasinejad Enger1,3, (1) McGill University, Montreal, QC, CA, (2) Jewish General Hospital, Montreal , QC, CA, (3) Lady Davis Institute, Montreal, Qc, CA.
|SU-IePD-TRACK 5-5||Integrating Rotatable Tandem Applicator to Conventional Ovoid Applicator for Complete Framework of Intensity Modulated Brachytherapy (IMBT) for Cervical Cancer|
H Kim1*, Y Goh2, D Kim1, J Kim1, Y Lim3, (1) Department of Radiation Oncology,Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, ,KR, (2) Department of Radiation Oncology, Asan Medical Center, Seoul, Korea, KR (5) National Cancer Center, Goyang-si, ,KR
|SU-IePD-TRACK 5-5||Improved Dosimetric Performance of VMAT Total Marrow Irradiation Using Knowledge-Based Planning Approach|
K Ahn1,2*, M Koshy1,2, J Partouche2, D Rondelli1, P Patel1, Y Hasan2, H Liu2, B Aydogan2, (1) University of Illinois at Chicago, Chicago, IL, (2) University of Chicago, Chicago, IL
|TH-C-TRACK 5-7||Commissioning of a Novel Compensator-Based IMRT System for Low- and Middle-Income Countries|
K Oh*/The University of Washington and The University of Texas MD Anderson Cancer Center, B Sengupta/The University of Washington, A Olanrewaju/The University of Texas MD Anderson Cancer Center, R Douglas/The University of Texas MD Anderson Cancer Center, K Roach/The University of Texas MD Anderson Cancer Center, C Cardenas/The University of Texas MD Anderson Cancer Center, L Court/The University of Texas MD Anderson Cancer Center, E Ford/The University of Washington
|TH-F-TRACK 4-4||Head-And-Neck IMRT Auto-Planning Through Fluence Map Prediction Using Progressive Growing of Generative Adversarial Networks|
X Li1*, QJ Wu1, Q Wu1, C Wang1, Y Sheng1, W Wang1, H Stephens1, F Yin1, Y Ge2, (1) Duke University Medical Center, Durham, NC, (2) University of North Carolina at Charlotte, Charlotte, NC
|WE-C-TRACK 3-7||Sensitivity Evaluation of Patient Specific Quality Assurance - Independent Assessment of Quality|
J Lehmann1,2,3*, M Hussein4, S Siva5, A Moore3,6, T Standen1, B Subramanian7, P Greer1,3, CH Clark4,8,9, (1) Calvary Mater Newcastle Hospital, Newcastle, AU (2) University of Sydney, Sydney, AU (3) University of Newcastle, Newcastle, AU (4) National Physical Laboratory, Teddington, UK (5) Peter MacCallum Cancer Centre, Melbourne, AU (6) TROG Cancer Research, Newcastle, AU (7) GenesisCare, Bundoora, AU (8) University College London Hospital, London, UK (9) National Radiotherapy Trials Quality Assurance Group, London, UK